15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 13 firms covering MetLife Inc, 11 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $90.00 to $106.00, so the covering firms are broadly aligned. The average target of $100.85 sits 3% above the current $97.50. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.53 next quarter toward $10.99 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS13 ratings
Strong Buy
Strong Buy00%
Buy1185%
Hold215%
Sell00%
Strong Sell00%
Based on 13 analysts giving stock ratings to MetLife Inc.
As of Jul, 11 of 13 firms rate MET a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MET EPS & revenue forecast
EPS · NEXT QUARTER
$2.53
Range $2.41 – $2.68 · 12 analysts · +7% YoY
Next period, 12 analysts expect MetLife Inc to earn $2.53 a share (range $2.41 – $2.68), versus $2.37 a year earlier. Full-year consensus is $9.85, growing to $10.99 the year after.
REVENUE · NEXT QUARTER
$20.1B
Range $19.8B – $20.6B · 12 analysts · +12% YoY
Revenue is expected to reach $20.1B (range $19.8B – $20.6B), +12.3% year-over-year. Full-year consensus is $79.7B, rising to $83.3B next year.
Top analysts covering MetLife Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MET.
#1
Alex Scott
Barclays · Rank #40
Buy
$94.00-3.6% to target
Overall win rate
52%
+ Follow
#2
Elyse Greenspan
Wells Fargo · Rank #44
Buy
$97.00-0.5% to target
Overall win rate
56%
+ Follow
#3
Paul Newsome
Piper Sandler · Rank #252
Hold
$90.00-7.7% to target
Overall win rate
45%
+ Follow
#4
RK
Ryan Krueger
Keefe, Bruyette & Woods
Buy
$105.00+7.7% to target
Coverage
—
+ Follow
#5
WC
Wesley Carmichael
Wells Fargo
Buy
$101.00+3.6% to target
Coverage
—
+ Follow
MET stock forecast FAQ
What is MET's average 12-month price target?+
The 13 analysts with a live target average $100.85 for MetLife Inc over the next 12 months, ranging from a $106.00 high to a $90.00 low.
Is MET stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 13 analyst ratings, 11 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MET?+
The Street-high target is $106.00 (JP Morgan), and the Street-low is $90.00 (Piper Sandler). The average of all 13 active targets is $100.85.
How many Wall Street analysts cover MET?+
13 analysts have an active rating on MetLife Inc, and 13 firms carry a live 12-month price target.
Who is the most accurate analyst covering MET?+
Among analysts who currently cover MET, Alex Scott of Barclays has the strongest overall Quantellect track record (Rank #40). Their current call is Buy with a $94.00 target.
What is MetLife Inc's projected EPS for next quarter?+
The consensus estimate is $2.53 per share (range $2.41 – $2.68) across 12 analysts. Full-year EPS is projected at $9.85, rising to $10.99 the following year.
How much revenue is MetLife Inc expected to report next quarter?+
Consensus revenue is $20.1B (range $19.8B – $20.6B). Full-year revenue is projected at $79.7B, growing to $83.3B next year.
Have analysts been upgrading or downgrading MET lately?+
As of Jul, 11 of 13 firms rate MET a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MET calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
